Enriched endogenous omega-3 fatty acids in mice protect against global ischemia injury

Journal of Lipid Research

Volumn 55, Issue 7, 2014, Pages 1288-1297

  Luo, Chuanming ^a   Ren, Huixia ^a   Wan, Jian Bo ^a   Yao, Xiaoli ^b   Zhang, Xiaojing ^a   He, Chengwei ^a   So, Kwok Fai ^c   Kang, Jing X ^d   Pei, Zhong ^b   Su, Huanxing ^a  

^a UNIVERSITY OF MACAU   (Macao)

^b THE FIRST AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^c JINAN UNIVERSITY   (China)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; CHEMICAL COMPOUND; DIHOMO GAMMA LINOLENIC ACID; DOCOSATETRAENOIC ACID; EICOSADIENOIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LINOLEIC ACID; MONOUNSATURATED FATTY ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; POLYUNSATURATED FATTY ACID; RESOLVIN D1; UNCLASSIFIED DRUG; CADHERIN; DOCOSAHEXAENOIC ACID; FATH PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CELL; BRAIN ISCHEMIA; CELL LOSS; CELL SURVIVAL; COGNITIVE DEFECT; CONTROLLED STUDY; DIET THERAPY; FAT 1 GENE; FATTY ACID ANALYSIS; FEMALE; GENE; GENE EXPRESSION; HIPPOCAMPAL CA1 REGION; LIPID DIET; MALE; MOUSE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; SPATIAL LEARNING; SPATIAL MEMORY; WILD TYPE; ANIMAL; GENETICS; METABOLISM; MUTANT MOUSE STRAIN; NERVE CELL; PATHOLOGY;

ANIMALS; BRAIN ISCHEMIA; CA1 REGION, HIPPOCAMPAL; CADHERINS; COGNITIVE DYSFUNCTION; DOCOSAHEXAENOIC ACIDS; MICE; MICE, MUTANT STRAINS; NEURONS;

EID: 84904019789     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M046466     Document Type: Article

References (65)

1. Harukuni, I., and A. Bhardwaj. 2006. Mechanisms of brain injury after global cerebral ischemia. Neurol. Clin. 24: 1-21.
2. Hossmann, K. A. 2008. Cerebral ischemia: models, methods and outcomes. Neuropharmacology. 55: 257-270.
3. Liou, A. K., R. S. Clark, D. C. Henshall, X. M. Yin, and J. Chen. 2003. To die or not to die for neurons in ischemia, traumatic brain injury and epilepsy: a review on the stress-activated signaling pathways and apoptotic pathways. Prog. Neurobiol. 69: 103-142.
4. Nitatori, T., N. Sato, S. Waguri, Y. Karasawa, H. Araki, K. Shibanai, E. Kominami, and Y. Uchiyama. 1995. Delayed neuronal death in the CA1 pyramidal cell layer of the gerbil hippocampus following transient ischemia is apoptosis. J. Neurosci. 15: 1001-1011.
5. Eady, T. N., L. Belayev, L. Khoutorova, K. D. Atkins, C. Zhang, and N. G. Bazan. 2012. Docosahexaenoic acid signaling modulates cell survival in experimental ischemic stroke penumbra and initiates long-term repair in young and aged rats. PLoS ONE. 7: e46151.
6. Kelly, L., B. Grehan, A. D. Chiesa, S. M. O'Mara, E. Downer, G. Sahyoun, K. A. Massey, A. Nicolaou, and M. A. Lynch. 2011. The polyunsaturated fatty acids, EPA and DPA exert a protective effect in the hippocampus of the aged rat. Neurobiol. Aging. 32: 2318e1-15.
7. Lalancette-H́bert, M., C. Julien, P. Cordeau, I. Bohacek, Y. C. Weng, F. Calon, and J. Kriz. 2011. Accumulation of dietary docosahexaenoicacid in the brain attenuates acute immune response and development of postischemic neuronal damage. Stroke. 42: 2903-2909.
8. Moreira, J. D., L. Knorr, A. P. Thomazi, F. Simao, C. Battu, J. P. Oses, C. Gottfried, S. Wofchuk, C. Salbego, D. O. Souza, et al. 2010. Dietary omega-3 fatty acids attenuate cellular damage after a hippocampal ischemic insult in adult rats. J. Nutr. Biochem. 21: 351-356.
9. Zhang, W., X. Hu, W. Yang, Y. Gao, and J. Chen. 2010. Omega-3 polyunsaturated fatty acid supplementation confers long-term neuroprotection against neonatal hypoxic-ischemic brain injury through anti-infl ammatory actions. Stroke. 41: 2341-2347.
10. Eltzschig, H. K., and T. Eckle. 2011. Ischemia and reperfusion-from mechanism to translation. Nat. Med. 17: 1391-1401.
11. Calder, P. C. 2013. Omega-3 polyunsaturated fatty acids and infl ammatory processes: nutrition or pharmacology? Br. J. Clin. Pharmacol. 75: 645-662.
12. Hjorth, E., and Y. Freund-Levi. 2012. Immunomodulation of microglia by docosahexaenoic acid and eicosapentaenoic acid. Curr. Opin. Clin. Nutr. Metab. Care. 15: 134-143.
13. Zhang, W., P. Li, X. Hu, F. Zhang, J. Chen, and Y. Gao. 2011. Omega-3 polyunsaturated fatty acids in the brain: metabolism and neuroprotection. Front. Biosci. ( Landmark Ed ). 16: 2653-2670.
14. Kang, J. X., J. Wang, L. Wu, and Z. B. Kang. 2004. Transgenic mice: fat-1 mice convert n-6 to n-3 fatty acids. Nature. 427: 504.
15. Gladman, S. J., W. Huang, S. N. Lim, S. C. Dyall, S. Boddy, J. X. Kang, M. M. Knight, J. V. Priestley, and A. T. Michael-Titus. 2012. Improved outcome after peripheral nerve injury in mice with increased levels of endogenous omega-3 polyunsaturated fatty acids. J. Neurosci. 32: 563-571.
16. He, C., X. Qu, L. Cui, J. Wang, and J. X. Kang. 2009. Improved spatial learning performance of fat-1 mice is associated with enhanced neurogenesis and neuritogenesis by docosahexaenoic acid. Proc. Natl. Acad. Sci. USA. 106: 11370-11375.
17. Wan, J. B., L. L. Huang, R. Rong, R. Tan, J. Wang, and J. X. Kang. 2010. Endogenously decreasing tissue n-6/n-3 fatty acid ratio reduces atherosclerotic lesions in apolipoprotein E-defi cient mice by inhibiting systemic and vascular infl ammation. Arterioscler. Thromb. Vasc. Biol. 30: 2487-2494.
18. Zhu, H., T. Yoshimoto, S. Imajo-Ohmi, M. Dazortsava, A. Mathivanan, and T. Yamashima. 2012. Why are hippocampal CA1 neurons vulnerable but motor cortex neurons resistant to transient ischemia? J. Neurochem. 120: 574-585.
19. Moskowitz, M. A., E. H. Lo, and C. Iadecola. 2010. The science of stroke: mechanisms in search of treatments. Neuron. 67: 181-198.
20. Ofengeim, D., Y. B. Chen, T. Miyawaki, H. Li, S. Sacchetti, R. J. Flannery, K. N. Alavian, F. Pontarelli, B. A. Roelofs, J. A. Hickman, et al. 2012. N-terminally cleaved Bcl-xL mediates ischemia-induced neuronal death. Nat. Neurosci. 15: 574-580.
21. Im, D. S. 2012. Omega-3 fatty acids in anti-infl ammation (pro-resolution) and GPCRs. Prog. Lipid Res. 51: 232-237.
22. Oh, D. Y., S. Talukdar, E. J. Bae, T. Imamura, H. Morinaga, W. Fan, P. Li, W. J. Lu, S. M. Watkins, and J. M. Olefsky. 2010. GPR120 is an omega-3 fatty acid receptor mediating potent anti-infl ammatory and insulin-sensitizing effects. Cell. 142: 687-698.
23. Crack, P. J., J. M. Taylor, U. Ali, A. Mansell, and P. J. Hertzog. 2006. Potential contribution of NF-kappaB in neuronal cell death in the glutathione peroxidase-1 knockout mouse in response to ischemiareperfusion injury. Stroke. 37: 1533-1538.
24. Schneider, A., A. Martin-Villalba, F. Weih, J. Vogel, T. Wirth, and M. Schwaninger. 1999. NF-kappaB is activated and promotes cell death in focal cerebral ischemia. Nat. Med. 5: 554-559.
25. Zhang, W., I. Potrovita, V. Tarabin, O. Herrmann, V. Beer, F. Weih, A. Schneider, and M. Schwaninger. 2005. Neuronal activation of NF-kappaB contributes to cell death in cerebral ischemia. J. Cereb. Blood Flow Metab. 25: 30-40.
26. Nurmi, A., P. J. Lindsberg, M. Koistinaho, W. Zhang, E. Juettler, M. L. Karjalainen-Lindsberg, F. Weih, N. Frank, M. Schwaninger, and J. Koistinaho. 2004. Nuclear factor-kappaB contributes to infarction after permanent focal ischemia. Stroke. 35: 987-991.
27. Hayden, M. S., and S. Ghosh. 2008. Shared principles in NF-kappaB signaling. Cell. 132: 344-362.
28. Okuyama, S., S. Minami, N. Shimada, N. Makihata, M. Nakajima, and Y. Furukawa. 2013. Anti-infl ammatory and neuroprotective effects of auraptene, a citrus coumarin, following cerebral global ischemia in mice. Eur. J. Pharmacol. 699: 118-123.
29. Pekny, M., and M. Nilsson. 2005. Astrocyte activation and reactive gliosis. Glia. 50: 427-434.
30. Simopoulos, A. P. 2006. Evolutionary aspects of diet, the omega-6/omega-3 ratio and genetic variation: nutritional implications for chronic diseases. Biomed. Pharmacother. 60: 502-507.
31. Karr, J. E., J. E. Alexander, and R. G. Winningham. 2011. Omega-3 polyunsaturated fatty acids and cognition throughout the lifespan: a review. Nutr. Neurosci. 14: 216-225.
32. Luchtman, D. W., and C. Song. 2013. Cognitive enhancement by omega-3 fatty acids from child-hood to old age: fi ndings from animal and clinical studies. Neuropharmacology. 64: 550-565.
33. Calon, F., G. P. Lim, F. Yang, T. Morihara, B. Teter, O. Ubeda, P. Rostaing, A. Triller, N. J. Salem, K. H. Ashe, et al. 2004. Docosahexaenoic acid protects from dendritic pathology in an Alzheimer's disease mouse model. Neuron. 43: 633-645.
34. Lukiw, W. J., J. G. Cui, V. L. Marcheselli, M. Bodker, A. Botkjaer, K. Gotlinger, C. N. Serhan, and N. G. Bazan. 2005. A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease. J. Clin. Invest. 115: 2774-2783.
35. Das, U. N., and K. S. Vaddadi. 2004. Essential fatty acids in Huntington's disease. Nutrition. 20: 942-947.
36. Huang, W. L., V. R. King, O. E. Curran, S. C. Dyall, R. E. Ward, N. Lal, J. V. Priestley, and A. T. Michael-Titus. 2007. A combination of intravenous and dietary docosahexaenoic acid signifi cantly improves outcome after spinal cord injury. Brain. 130: 3004-3019.
37. King, V. R., W. L. Huang, S. C. Dyall, O. E. Curran, J. V. Priestley, and A. T. Michael-Titus. 2006. Omega-3 fatty acids improve recovery, whereas omega-6 fatty acids worsen outcome, after spinal cord injury in the adult rat. J. Neurosci. 26: 4672-4680.
38. Lim, S. N., W. Huang, J. C. Hall, R. E. Ward, J. V. Priestley, and A. T. Michael-Titus. 2010. The acute administration of eicosapentaenoic acid is neuroprotective after spinal cord compression injury in rats. Prostaglandins Leukot. Essent. Fatty Acids. 83: 193-201.
39. Ward, R. E., W. Huang, O. E. Curran, J. V. Priestley, and A. T. Michael-Titus. 2010. Docosahexaenoic acid prevents white matter damage after spinal cord injury. J. Neurotrauma. 27: 1769-1780.
40. Belayev, L., L. Khoutorova, K. D. Atkins, T. N. Eady, S. Hong, Y. Lu, A. Obenaus, and N. G. Bazan. 2011. Docosahexaenoic Acid Therapy of Experimental Ischemic Stroke. Transl Stroke Res. 2: 33-41.
41. Mishina, M., K. Kim, S. Kominami, T. Mizunari, S. Kobayashi, and Y. Katayama. 2013. Impact of polyunsaturated fatty acid consumption prior to ischemic stroke. Acta Neurol. Scand. 127: 181-185.
42. Mozaffarian, D., and J. H. Wu. 2011. Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events. J. Am. Coll. Cardiol. 58: 2047-2067.
43. Plamondon, H., and M. C. Roberge. 2008. Dietary PUFA supplements reduce memory defi cits but not CA1 ischemic injury in rats. Physiol. Behav. 95: 492-500.
44. de Lorgeril, M., and P. Salen. 2012. New insights into the health effects of dietary saturated and omega-6 and omega-3 polyunsaturated fatty acids. BMC Med. 10: 50.
45. Lebbadi, M., C. Julien, A. Phivilay, C. Tremblay, V. Emond, J. X. Kang, and F. Calon. 2011. Endogenous conversion of omega-6 into omega-3 fatty acids improves neuropathology in an animal model of Alzheimer's disease. J. Alzheimers Dis. 27: 853-869.
46. Loef, M., and H. Walach. 2013. The omega-6/omega-3 ratio and dementia or cognitive decline: a systematic review on human studies and biological evidence. J Nutr Gerontol Geriatr. 32: 1-23.
47. Das, U. N., and L. G. Puskas. 2009. Transgenic fat-1 mouse as a model to study the pathophysiology of cardiovascular, neurological and psychiatric disorders. Lipids Health Dis. 8: 61.
48. Berquin, I. M., Y. Min, R. Wu, J. Wu, D. Perry, J. M. Cline, M. J. Thomas, T. Thornburg, G. Kulik, A. Smith, et al. 2007. Modulation of prostate cancer genetic risk by omega-3 and omega-6 fatty acids. J. Clin. Invest. 117: 1866-1875.
49. Bousquet, M., K. Gue, V. Emond, P. Julien, J. X. Kang, F. Cicchetti, and F. Calon. 2011. Transgenic conversion of omega-6 into omega-3 fatty acids in a mouse model of Parkinson's disease. J. Lipid Res. 52: 263-271.
50. Hudert, C. A., K. H. Weylandt, Y. Lu, J. Wang, S. Hong, A. Dignass, C. N. Serhan, and J. X. Kang. 2006. Transgenic mice rich in endogenous omega-3 fatty acids are protected from colitis. Proc. Natl. Acad. Sci. USA. 103: 11276-11281.
51. Lim, S. N., S. J. Gladman, S. C. Dyall, U. Patel, N. Virani, J. X. Kang, J. V. Priestley, and A. T. Michael-Titus. 2013. Transgenic mice with high endogenous omega-3 fatty acids are protected from spinal cord injury. Neurobiol. Dis. 51: 104-112.
52. Zukin, R. S. J. T. Y. H. 2004. Molecular and cellular mechanisms of ischemia-induced neuronal death. In: Stroke: pathophysiology, diagnosis, and management. In. Churchill Livingstone Elsevier, Philadelphia. 829-854.
53. Sugawara, T., M. Fujimura, Y. Morita-Fujimura, M. Kawase, and P. H. Chan. 1999. Mitochondrial release of cytochrome c corresponds to the selective vulnerability of hippocampal CA1 neurons in rats after transient global cerebral ischemia. J. Neurosci. 19: R C39.
54. Jin, K., S. H. Graham, X. Mao, T. Nagayama, R. P. Simon, and D. A. Greenberg. 2001. Fas (CD95) may mediate delayed cell death in hippocampal CA1 sector after global cerebral ischemia. J. Cereb. Blood Flow Metab. 21: 1411-1421.
55. Li, H., H. Zhu, C. J. Xu, and J. Yuan. 1998. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell. 94: 491-501.
56. Chan, P. H. 2001. Reactive oxygen radicals in signaling and damage in the ischemic brain. J. Cereb. Blood Flow Metab. 21: 2-14.
57. Oikawa, S., T. Yamada, T. Minohata, H. Kobayashi, A. Furukawa, S. Tada-Oikawa, Y. Hiraku, M. Murata, M. Kikuchi, and T. Yamashima. 2009. Proteomic identifi cation of carbonylated proteins in the monkey hippocampus after ischemia-reperfusion. Free Radic. Biol. Med. 46: 1472-1477.
58. Giffard, R. G., R. Q. Han, J. F. Emery, M. Duan, and J. F. Pittet. 2008. Regulation of apoptotic and infl ammatory cell signaling in cerebral ischemia: the complex roles of heat shock protein 70. Anesthesiology. 109: 339-348.
59. Moraes, L. A., L. Piqueras, and D. Bishop-Bailey. 2006. Peroxisome proliferator-activated receptors and infl ammation. Pharmacol. Ther. 110: 371-385.
60. Lee, J. Y., J. Ye, Z. Gao, H. S. Youn, W. H. Lee, L. Zhao, N. Sizemore, and D. H. Hwang. 2003. Reciprocal modulation of Toll-like receptor-4 signaling pathways involving MyD88 and phosphatidylinositol 3-kinase/AKT by saturated and polyunsaturated fatty acids. J. Biol. Chem. 278: 37041-37051.
61. Colbourne, F., H. Li, and A. M. Buchan. 1999. Indefatigable CA1 sector neuroprotection with mild hypothermia induced 6 hours after severe forebrain ischemia in rats. J. Cereb. Blood Flow Metab. 19: 742-749.
62. DeBow, S., and F. Colbourne. 2003. Brain temperature measurement and regulation in awake and freely moving rodents. Methods. 30: 167-171.
63. Arita, M., F. Bianchini, J. Aliberti, A. Sher, N. Chiang, S. Hong, R. Yang, N. A. Petasis, and C. N. Serhan. 2005. Stereochemical assignment, antiinfl ammatory properties, and receptor for the omega-3 lipid mediator resolvin E1. J. Exp. Med. 201: 713-722.
64. Bazan, N. G. 2009. Cellular and molecular events mediated by docosahexaenoic acid-derived neuroprotectin D1 signaling in photoreceptor cell survival and brain protection. Prostaglandins Leukot. Essent. Fatty Acids. 81: 205-211.
65. Bousquet, M., C. Gibrat, M. Saint-Pierre, C. Julien, F. Calon, and F. Cicchetti. 2009. Modulation of brain-derived neurotrophic factor as a potential neuroprotective mechanism of action of omega-3 fatty acids in a parkinsonian animal model. Prog. Neuropsychopharmacol. Biol. Psychiatry. 33: 1401-1408.